AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 78 filers reported holding AVALO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 45,000,000 | $98,100,000 | 1.66% |
| Integral Health Asset Management, LLC | 1,625,000 | $3,543,000 | 1.02% |
| Stonepine Capital Management, LLC | 850,000 | $1,853,000 | 0.84% |
| Asymmetry Capital Management, L.P. | 534,621 | $1,165,000 | 0.70% |
| Opaleye Management Inc. | 1,459,400 | $3,181,000 | 0.59% |
| Nantahala Capital Management | 6,952,401 | $15,156,000 | 0.48% |
| Ikarian Capital, LLC | 718,705 | $1,566,000 | 0.11% |
| Monashee Investment Management LLC | 270,000 | $589,000 | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,204,930 | $2,627,000 | 0.07% |
| Point72 Asset Management, L.P. | 6,008,850 | $13,099,000 | 0.06% |